GlassScriptPhysician profile
Hardeep Kataria
NPI 1043564362
$116,152.31
in general payments reported to CMS, 2019-2025
26 companies · $29K in 2025
The $29K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $642 · 2021: $652 · 2022: $9,013 · 2023: $32K · 2024: $44K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $30K · Consulting Fee: $28K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Travel and Lodging: $14K · Food and Beverage: $9,689 · Entertainment: $231 · Education: $9.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $29,882.50 |
| Consulting Fee | $28,205.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,181.66 |
| Travel and Lodging | $14,289.81 |
| Food and Beverage | $9,689.44 |
| Entertainment | $231.11 |
| Education | $9.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $36,563.93 | 2021-2025 | |
| Dompe US, INC. | $25,654.70 | 2022-2025 | Oxervate |
| Alcon Vision LLC | $15,380.45 | 2022-2025 | Precision 1, Total30, Dailies Total1 |
| Sight Sciences, INC. | $14,375.10 | 2020-2024 | Tearcare System |
| Oyster Point Pharma, INC. | $7,933.52 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $5,726.44 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Alcon Research LLC | $2,560.00 | 2024-2025 | Tryptyr |
| Tarsus Pharmaceuticals, INC. | $2,266.94 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $2,085.37 | 2019-2025 | Cequa, Xelpros, Bromsite |
| Novartis Pharmaceuticals Corporation | $755.79 | 2019-2022 | |
| Lumenis Be INC | $582.77 | 2023-2025 | Optilight |
| Coopervision INC. | $552.25 | 2022-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Allergan, INC. | $361.79 | 2019-2022 | |
| Optos, INC. | $360.31 | 2022-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $228.38 | 2022-2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $162.87 | 2019-2021 | |
| Harrow Eye, LLC | $133.70 | 2025 | Vevye |
| Apellis Pharmaceuticals, INC. | $121.24 | 2023 | |
| Visioneering Technologies, INC. | $111.94 | 2025 | |
| Horizon Therapeutics Plc | $79.81 | 2023 | Tepezza |
| Akorn Operating Company LLC | $39.87 | 2021 | |
| Shire North American Group INC | $38.97 | 2019 | |
| Thea Pharma INC. | $23.50 | 2022 | |
| Kala Pharmaceuticals, INC. | $20.07 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Aerie Pharmaceuticals, INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hardeep Kataria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.